Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junbo Ge

Showing results (761-770 of 1,174) with videos related to

Pageof 118
Sort By:
Current Pharmaceutical Design|December 24, 2021
Sodium Tanshinone IIA Sulfonate Improves Adverse Ventricular Remodeling Post-MI by Reducing Myocardial Necrosis, Modulating Inflammation, and Promoting AngiogenesisBaoli Zhang, Peng Yu, Enyong Su, et al.
Journal of Cellular Biochemistry|March 11, 2014
Insulin-like growth factor binding protein 4 enhances cardiomyocytes induction in murine-induced pluripotent stem cellsYuanyuan Xue, Yuan Yan, Hui Gong, et al.
JACC. Cardiovascular Interventions|February 22, 2014
A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trialBo Xu, Runlin Gao, Jian'an Wang, et al.
American Heart Journal|September 18, 2012
REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)Dong Huang, Juying Qian, Lei Ge, et al.
Respiratory Research|February 23, 2025
The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort studyMingfei Li, Dandan Chen, Jianing Fan, et al.
Clinical Cardiology|July 3, 2018
Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trialAlberto J Lorenzatti, Freddy G Eliaschewitz, Yundai Chen, et al.
British Journal of Pharmacology|June 23, 2022
Caspase-4/11 is critical for angiogenesis by repressing Notch1 signalling via inhibiting γ-secretase activityLinlin Fan, Hao Liu, Guofu Zhu, et al.
BMC Cardiovascular Disorders|March 6, 2020
The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarctionShuning Zhang, Xin Deng, Wenlong Yang, et al.
Journal of Cardiothoracic Surgery|June 29, 2024
2-year results and myocardial impact of transapical mitral valve repair in patients with primary mitral regurgitation: an echocardiographic studyChunqiang Hu, Zhenyi Ge, Wei Li, et al.
Cell Death Discovery|October 26, 2020
Cardiomyocyte-restricted high-mobility group box 1 (HMGB1) deletion leads to small heart and glycolipid metabolic disorder through GR/PGC-1α signallingPeng Yu, Ming Liu, Baoli Zhang, et al.
Pageof 118

Showing results (761-770 of 1,174) with videos related to

Sort By:
Pageof 118
Current Pharmaceutical Design|December 24, 2021
Sodium Tanshinone IIA Sulfonate Improves Adverse Ventricular Remodeling Post-MI by Reducing Myocardial Necrosis, Modulating Inflammation, and Promoting AngiogenesisBaoli Zhang, Peng Yu, Enyong Su, et al.
Journal of Cellular Biochemistry|March 11, 2014
Insulin-like growth factor binding protein 4 enhances cardiomyocytes induction in murine-induced pluripotent stem cellsYuanyuan Xue, Yuan Yan, Hui Gong, et al.
JACC. Cardiovascular Interventions|February 22, 2014
A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trialBo Xu, Runlin Gao, Jian'an Wang, et al.
American Heart Journal|September 18, 2012
REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)Dong Huang, Juying Qian, Lei Ge, et al.
Respiratory Research|February 23, 2025
The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort studyMingfei Li, Dandan Chen, Jianing Fan, et al.
Clinical Cardiology|July 3, 2018
Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trialAlberto J Lorenzatti, Freddy G Eliaschewitz, Yundai Chen, et al.
British Journal of Pharmacology|June 23, 2022
Caspase-4/11 is critical for angiogenesis by repressing Notch1 signalling via inhibiting γ-secretase activityLinlin Fan, Hao Liu, Guofu Zhu, et al.
BMC Cardiovascular Disorders|March 6, 2020
The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarctionShuning Zhang, Xin Deng, Wenlong Yang, et al.
Journal of Cardiothoracic Surgery|June 29, 2024
2-year results and myocardial impact of transapical mitral valve repair in patients with primary mitral regurgitation: an echocardiographic studyChunqiang Hu, Zhenyi Ge, Wei Li, et al.
Cell Death Discovery|October 26, 2020
Cardiomyocyte-restricted high-mobility group box 1 (HMGB1) deletion leads to small heart and glycolipid metabolic disorder through GR/PGC-1α signallingPeng Yu, Ming Liu, Baoli Zhang, et al.
Pageof 118